Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1900303	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2019-03-21	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2019-04-12	view
JYHB1600808	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2016-06-27	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2017-01-03	view
JYHB1800938	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2018-08-07	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-01-10	view
JYHZ2000244	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	License Renew	2020-11-12	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	In Review	2020-11-11	view
JYHB1800652	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2018-06-08	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2018-06-21	view
JYHB2000122	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2020-02-26	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-04-23	view
JYHZ2000243	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	License Renew	2020-11-12	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	In Review	2020-11-11	view
JYHB1800651	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2018-06-08	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2018-06-21	view
JYHB1900247	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2019-02-27	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2019-03-21	view
JYHB1800650	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2018-06-08	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2018-06-21	view
JYHB2000121	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2020-02-26	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-04-23	view
JYHZ2000242	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	License Renew	2020-11-12	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	In Review	2020-11-11	view
JYHB1601444	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2016-10-27	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2018-09-04	view
JYHB2001690	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2020-09-04	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2020-09-15	view
JYHB1800653	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2018-06-08	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2018-06-21	view
JYHZ2000241	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	License Renew	2020-11-12	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	In Review	2020-11-11	view
JYHB1601445	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2016-10-27	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2018-09-04	view
JYHB1800937	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2018-08-15	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-01-10	view
JYHB2001689	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2020-09-04	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2020-09-15	view
JYHB2002192	醋酸戈舍瑞林缓释植入剂	goserelin acetate	Implant	Chemical Drugs	Supplementary Application	2020-10-30	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Filed	2020-11-17	view